These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 7996849)
1. The use of biodegradable amikacin microspheres to prevent vascular graft infection. Ney AL; Granja JA; Schuster PA; Tsukayama DT; Jacobs DM; Bubrick MP J Surg Res; 1994 Dec; 57(6):698-705. PubMed ID: 7996849 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of collagen silver-coated polyester and rifampin-soaked vascular grafts to resist infection from MRSA and Escherichia coli in a dog model. Schneider F; O'Connor S; Becquemin JP Ann Vasc Surg; 2008 Nov; 22(6):815-21. PubMed ID: 18835516 [TBL] [Abstract][Full Text] [Related]
3. Local treatment of prosthetic vascular graft infection with multivesicular liposome-encapsulated amikacin. Huh J; Chen JC; Furman GM; Malki C; King B; Kafie F; Wilson SE J Surg Res; 1998 Jan; 74(1):54-8. PubMed ID: 9536974 [TBL] [Abstract][Full Text] [Related]
4. Prevention of Staphylococcus aureus graft infection by a new gelatin-sealed vascular graft prebonded with antibiotics. Javerliat I; Goëau-Brissonnière O; Sivadon-Tardy V; Coggia M; Gaillard JL J Vasc Surg; 2007 Nov; 46(5):1026-31. PubMed ID: 17905555 [TBL] [Abstract][Full Text] [Related]
5. [Experimental examination concerning the efficacy of silver-coated Dacron prostheses in vascular graft infections following subcutaneous implantation in a standardized infection model]. Hernández-Richter T; Wittmann F; Mayr S; Schmitt-Sody M; Blasenbreu S; Wichmann M; Heiss MM; Schardey HM; Angele MK Zentralbl Chir; 2003 Mar; 128(3):244-9. PubMed ID: 12739511 [TBL] [Abstract][Full Text] [Related]
6. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection? Vicaretti M; Hawthorne W; Ao PY; Fletcher JP Int Angiol; 1999 Sep; 18(3):225-32. PubMed ID: 10688422 [TBL] [Abstract][Full Text] [Related]
7. Use of cefazolin microspheres to treat localized methicillin-resistant Staphylococcus aureus infections in rats. Fallon MT; Shafer W; Jacob E J Surg Res; 1999 Sep; 86(1):97-102. PubMed ID: 10452874 [TBL] [Abstract][Full Text] [Related]
8. Systemic and local antibiotic prophylaxis in the prevention of prosthetic vascular graft infection: an experimental study. Lehnhardt FJ; Torsello G; Claeys LG; Pfeiffer M; Wachol-Drewek Z; Grundmann RT; Sandmann W Eur J Vasc Endovasc Surg; 2002 Feb; 23(2):127-33. PubMed ID: 11863329 [TBL] [Abstract][Full Text] [Related]
9. Absorbable, delayed-release antibiotic beads reduce surgical wound infection. Galandiuk S; Wrightson WR; Young S; Myers S; Polk HC Am Surg; 1997 Sep; 63(9):831-5. PubMed ID: 9290532 [TBL] [Abstract][Full Text] [Related]
10. Fibrin glue-antibiotic suspension in the prevention of prosthetic graft infection. Ney AL; Kelly PH; Tsukayama DT; Bubrick MP J Trauma; 1990 Aug; 30(8):1000-5; discussion 1005-6. PubMed ID: 2201786 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of bioabsorbable antibiotic containing bone screw in the prevention of biomaterial-related infection due to Staphylococcus aureus. Mäkinen TJ; Veiranto M; Knuuti J; Jalava J; Törmälä P; Aro HT Bone; 2005 Feb; 36(2):292-9. PubMed ID: 15780955 [TBL] [Abstract][Full Text] [Related]
12. Enhanced perigraft angiogenesis prevents prosthetic graft infection. Sato S; Nitta Y; Saiki Y; Kawamoto S; Iguchi A; Kaku M; Tabata Y; Tabayashi K Ann Thorac Surg; 2008 Oct; 86(4):1278-84. PubMed ID: 18805176 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat. Yasim A; Gul M; Atahan E; Ciragil P; Aral M; Ergun Y Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):274-9. PubMed ID: 16360328 [TBL] [Abstract][Full Text] [Related]
17. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421 [TBL] [Abstract][Full Text] [Related]
18. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection? Vicaretti M; Hawthorne W; Ao PY; Fletcher JP Int Angiol; 2000 Jun; 19(2):158-65. PubMed ID: 10905800 [TBL] [Abstract][Full Text] [Related]
20. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model. Atahan E; Gul M; Ergun Y; Eroglu E Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]